Prof. Eliezer M. Van Allen, Dana-Farber Cancer Institute, United States
Is artificial intelligence poised to revolutionize cancer diagnosis and treatment? Are we standing on the verge of an explosive breakthrough, or are real clinical impacts already emerging? As algorithms begin to influence clinical decision-making, how should the medical community establish safeguards for fairness, transparency, and ethics?
In this video, Prof. Van Allen shares forward-looking insights on the evolving role of AI in oncology and the opportunities and responsibilities that accompany this transformation.